Pilot Study Evaluating Outpatient Management of Tubo-ovarian Abscesses
- Conditions
- Pelvic Inflammatory DiseaseAbscessPelvic Infection
- Interventions
- Procedure: ultrasound transvaginal drainageProcedure: laparoscopy
- Registration Number
- NCT05408624
- Lead Sponsor
- Nantes University Hospital
- Brief Summary
Pelvic inflammatory diseases (PID) require antibiotic treatment. Among PID, the investigators distinguish: pelvi-peritonitis and pelvic collections such as Douglas abscess and/or tubo-ovarian abscess (TOA).
Recent recommendations published in December 2018 by the National College of French Gynecologists and Obstetricians (CNGOF) suggest that it is preferable to drain TOA when their size is greater than 3-4 cm. Ultrasound-guided transvaginal drainage is recommended as first-line treatment because of its ease of performance and its effectiveness. In the literature, many authors have demonstrated the feasibility and efficacy of transvaginal drainage associated with antibiotics in the treatment of TOA. Since ultrasound-guided transvaginal drainage is a less invasive alternative therapeutic procedure than laparoscopy for the drainage of TOA, it would be compatible with outpatient management. This mode of management can be carried out in a dedicated outpatient or functional exploration room with the help of a nurse but without an anesthetic team present. This gesture is simple and short-lived. In addition, the antibiotics used have pharmacological properties allowing oral intake from their initiation.
The investigators have proposed a new service protocol to treat TOA in this outpatient mode. The investigators therefore wish to analyze this new protocol from these three angles: 1/ the feasibility of this care, 2/ the quality of life of the patients through questionnaires given throughout the care and 3/ an evaluation of the 'efficiency.
- Detailed Description
Pelvic inflammatory diseases (PID) require antibiotic treatment. Among PID, the investigators distinguish: pelvi-peritonitis and pelvic collections such as Douglas abscess and/or tubo-ovarian abscess (TOA).
Recent recommendations published in December 2018 by the National College of French Gynecologists and Obstetricians (CNGOF) suggest that it is preferable to drain TOA when their size is greater than 3-4 cm. Ultrasound-guided transvaginal drainage is recommended as first-line treatment because of its ease of performance and its effectiveness. In the literature, many authors have demonstrated the feasibility and efficacy of transvaginal drainage associated with antibiotics in the treatment of TOA. Since ultrasound-guided transvaginal drainage is a less invasive alternative therapeutic procedure than laparoscopy for the drainage of TOA, it would be compatible with outpatient management. This mode of management can be carried out in a dedicated outpatient or functional exploration room with the help of a nurse but without an anesthetic team present. This gesture is simple and short-lived. In addition, the antibiotics used have pharmacological properties allowing oral intake from their initiation.
The investigators have proposed a new service protocol to treat TOA in this outpatient mode. The investigators therefore wish to analyze this new protocol from these three angles: 1/ the feasibility of this care, 2/ the quality of life of the patients through questionnaires given throughout the care and 3/ an evaluation of the 'efficiency.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 60
- Major patient at the time of inclusion
- Patient with diagnosis of TOA with a latero-uterine mass measuring at least 3 cm
-
Patient with severity criteria requiring hospitalization:
- Clinical severity criteria: haemodynamically unstable patient, septic shock, defense or contracture, sepsis, pelviperitonitis
- Comorbidities: diabetic imbalance, curative anticoagulation
-
Patient with a formal indication for laparoscopy:
- Diagnostic doubt with suspicion of an associated oncological or digestive pathology
- Presence of an intra-abdominal intrauterine device (IUD)
- Abscess not accessible vaginally
-
Patient who does not meet the eligibility criteria for outpatient hospitalization defined by French High Autority of Health
-
Patient under guardianship or curatorship
-
Patient does not speak French
-
Patient not benefiting from social security coverage
-
Current pregnancy
-
Confirmed allergy to one of the antibiotics (ceftriaxone, metronidazole or doxycycline)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description retrospective group - ultrasound transvaginal drainage ultrasound transvaginal drainage Patients with TOA in 2016, 2017 and 2018 with ultrasound-guided transvaginal drainage in conventional hospitalization prospective group - ultrasound transvaginal drainage ultrasound transvaginal drainage Patients with TOA with ultrasound-guided transvaginal drainage with outpatient management retrospective group - laparoscopy laparoscopy Patients with TOA in 2016, 2017 and 2018 with laparoscopy in conventional hospitalization
- Primary Outcome Measures
Name Time Method Cure rate one month The cure rate is defined by a composite criterion at 1 month of the procedure:
* Apyrexia (temperature \<38,0°c)
* Absence of re-intervention for pelvic collection (TOA) in the month following the transvaginal drainage
* Absence of second-line antibiotic therapy, extension, new antibiotic in the month following the transvaginal drainage
- Secondary Outcome Measures
Name Time Method Rehospitalization 1 month Rehospitalization: reason, duration and care
complications 1 month Presence of complications (digestive, urinary, parietal)
Quality of life with Patient Global Impression of Improvement (PGI-I) questionnaires 1 month Satisfaction and Quality of life , questionnaires completed by the patients on the day of the drainage before the procedure, at 48 hours and at 1 month The PGI-I is a transition scale that is a single question asking the patient to rate their urinary tract condition now, as compared with how it was prior to before beginning treatment on a scale from 1. Very much better to 7. Very much worse.
Evaluation of the direct costs 1 month Evaluation of the direct costs of care for the 3 treatment strategies for complicated IGH of the ATO type, according to a time horizon of 1 month and a collective perspective
Quality of life with EQ-5D-5L 1 month Satisfaction and Quality of life completed by the patients on the day of the drainage before the procedure, at 48 hours and at 1 month
eligibility 2 years Number of patients included in the protocol compared to the number of eligible patients
Discharge 2 years Discharge from hospital within 24 hours of the drainage
antibiotic therapy 1 month Change of antibiotic therapy (except adequate adaptation to the antibiogram). Change of antibiotic therapy is assessed by the need to add another antibiotic with a broader spectrum of action, following a poor clinical or biological evolution.
Quality of life with Medical Outcome Study Short Form 12 (SF12) 1 month Satisfaction and Quality of life, questionnaires completed by the patients on the day of the drainage before the procedure, at 48 hours and at 1 month.
Each question is assessed on a Likert scale, with 5 to 6 possible levels of response possible responses. The 8 dimensions combine synthetic information to calculate a physical composite score (PCS) and a mental score (SCP) and a mental composite score (SCM). The higher the score, the greater the patient's ability.Measure of Pain 1 month Pain is assessed by Numerical Rating Scale (NRS) (0-10). Absence of pain (EN=0/10), mild pain (EN\<4/10), absence of metrorrhagia and absence of leucorrhoea
residual mass 1 month Absence of residual mass ≥ 3cm on pelvic ultrasound
Trial Locations
- Locations (1)
CHU Nantes
🇫🇷Nantes, France